NCT00497367View on ClinicalTrials.gov

Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

June 30, 2013

Conditions
Cardiovascular Diseases
Interventions
DEVICE

Percutaneous Coronary Intervention (PCI) TAXUS Petal

TAXUS Petal, paclitaxel eluting stent

Trial Locations (4)

1003

Mercy Angiography Unit, 98 Mountain Road, First Floor, Auckland

1030

Auckland City Hospital, Cardiac Investigations Unit, Park Road, Auckland

53721

HELIOS Klinikum Siegburg, Ringstrasse 49, Siegburg

91349

Institut Hospitalier Jacques Cartier-ICPS, 6, Avenue du Noyer Lambert, Massy

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT00497367 - Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System | Biotech Hunter | Biotech Hunter